Welcome to our dedicated page for Allstate SEC filings (Ticker: ALL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Allstate Corporation filings document the insurer's operating results, Regulation FD updates, governance matters and registered capital structure. Recent Form 8-K reports include quarterly and annual financial results, investor supplements, estimated catastrophe losses and policies in force for Allstate Protection.
Allstate's proxy materials describe board matters, executive compensation and shareholder voting items. Its filing cover pages identify common stock, fixed-to-floating subordinated debentures due 2053, and depositary shares representing Series H, Series I and Series J noncumulative preferred stock registered on public exchanges.
Insider award of 7,115 restricted stock units at no cost, vesting in three equal annual installments. An executive officer, Zulfikar Jeevanjee (EVP & CTO - AIC), was granted 7,115 Restricted Stock Units (RSUs) on 10/03/2025 under The Allstate Corporation 2019 Equity Incentive Plan. Each RSU converts to one share of Allstate common stock without payment on the conversion dates. The RSUs vest in three equal increments on 10/03/2026, 10/03/2027, and 10/03/2028. The reported grant shows 0 purchase price per unit and results in 7,115 shares beneficially owned following the award.
Allstate Corporation reported that its Chief Financial Officer, John E. Dugenske, received an award of 4,743 restricted stock units (RSUs) on 10/03/2025 under the 2019 Equity Incentive Plan. Each RSU converts to one share of common stock at no cost to the recipient and the award will vest in three equal installments on 10/03/2026, 10/03/2027, and 10/03/2028. Following the grant, Mr. Dugenske beneficially owns 4,743 shares tied to these RSUs. The Form 4 filing was signed by an attorney-in-fact on 10/07/2025.
Form 144 notice for Allstate Corporation (ALL) reports a proposed sale of 33,614 shares of common stock through Goldman Sachs & Co. LLC on 10/06/2025 on the NYSE. The filing shows the shares were acquired as performance-award compensation on 02/17/2022 (18,989 shares), 02/18/2021 (11,536 shares) and 02/08/2019 (3,089 shares). The table lists an aggregate market value of $7,019,611.62 and a total outstanding share count of 263,505,334. No sales by the reporting person in the prior three months are reported. The filer certifies they are not aware of undisclosed material adverse information and includes the standard Rule 10b5-1/trading-plan notice language.
Margaret M. Keane, a director of The Allstate Corporation (ALL), reported an acquisition of common stock on 10/01/2025. The Form 4 shows she received 160 shares at a price of $210.68 each as an election to take stock instead of cash compensation under the company’s 2017 Equity Compensation Plan for Non-Employee Directors. After the transaction the filing reports 16,276.677 shares beneficially owned (listed with a footnote marker). The Form 4 was signed by an attorney-in-fact on 10/03/2025. The filing identifies her relationship to the issuer as Director and indicates this was a one-person Form 4 filing.
Perry M. Traquina, a director of The Allstate Corporation (ALL), reported acquiring 195 shares of common stock on 10/01/2025 at a price of $210.68 per share by electing to receive stock instead of cash compensation under the company’s 2017 Equity Compensation Plan for Non-Employee Directors. After that transaction the reporting person directly beneficially owned 5,407.125 shares. Separately, the filing shows 7,665.992 common share units held under the Amended and Restated Deferred Compensation Plan for Non-Employee Directors, which represent deferred director fees and include dividend-equivalent units; 36.215 of those units were acquired as dividend equivalents for the period 7/03/2025 through 10/01/2025. The form is signed by an attorney-in-fact on behalf of the reporting person.
Richard T. Hume, a director of The Allstate Corporation (ALL), reported the conversion of 1,300 restricted stock units into 1,300 shares of common stock on 06/01/2025 under The Allstate Corporation 2017 Equity Compensation Plan for Non-Employee Directors. The conversion required no payment ($0) and increased his total beneficial ownership to 3,909 shares. The filing indicates the transaction code M and was signed on behalf of Mr. Hume by Meghan E. Jauhar as attorney-in-fact.
The Allstate Corporation filed a Form 8-K to share information under Regulation FD. The company states that its August 2025 monthly release, which announces estimated catastrophe losses and policies in force, has been posted on allstateinvestors.com and is included as Exhibit 99, a press release dated September 18, 2025. The exhibit is furnished rather than filed, meaning it is provided for informational purposes under the Regulation FD disclosure rules.
The Allstate Corporation filed a Form 8-K to share information under Regulation FD. The company states that its August 2025 monthly release, which announces estimated catastrophe losses and policies in force, has been posted on allstateinvestors.com and is included as Exhibit 99, a press release dated September 18, 2025. The exhibit is furnished rather than filed, meaning it is provided for informational purposes under the Regulation FD disclosure rules.
Suren Gupta, an officer of The Allstate Corporation (ALL), reported transactions on 09/06/2025 converting 13,898 previously awarded restricted stock units (RSUs) into 13,898 common shares under the 2019 Equity Incentive Plan without payment of consideration. After that conversion the filing shows 107,188 shares beneficially owned directly.
The filing also reports a sale of 6,157 shares on 09/06/2025 at an average price of $201.53, reducing direct ownership to 101,031 shares. Indirect holdings include 1,330 shares held via a 401(k) plan and 7 shares via VVG Holdings LLC. The Form 4 is signed by an attorney-in-fact and reflects routine equity compensation and an open-market disposition.
Thomas J. Wilson, Chairman, President & CEO of The Allstate Corporation (ALL), reported changes in indirect holdings of company stock options on August 22, 2025. The filing shows assignments among related trusts: the Thomas J. Wilson 2023-A GRAT Trust transferred 100% of membership interests in TJW Options LLC 2018 Series Last Third to the Thomas J. Wilson 2020 GRAT Remainder Trust and transferred 10.654% of membership interests in TJW Options LLC 2019 Series Middle Third to the same remainder trust. The Form 4 lists multiple employee stock options with exercise prices of $92.80 and $92.46, underlying common stock amounts shown at 75,802, 89,915, and other tranche balances. Some tranches show dispositions to zero while others remain indirectly owned by TJW Options LLC.
Mark Q. Prindiville, Executive Vice President & Chief Risk Officer of The Allstate Corporation (ALL), reported option exercise and multiple open-market sales on 08/22/2025. He exercised employee stock options to acquire 7,383 shares at an exercise price of $62.32 (options granted 02/11/2019, exercisable through 02/11/2026) and immediately sold a series of shares: 3,019 shares at a weighted average of $205.3347, 1,265 shares at $206.8183, 2,984 shares at $207.3099, and 115 shares at $208.2636. Following these transactions, he beneficially owned 22,274 shares directly and 0 shares indirectly, with an additional 0 shares held indirectly through a 401(k) plan noted as 0. The Form 4 was signed by an attorney-in-fact on 08/26/2025.